What should be monitored during voriconazole administration?

Monitoring liver function tests and visual function during voriconazole administration is essential due to the drug's metabolism and potential side effects. Voriconazole is primarily metabolized by the liver, and practitioners must assess liver function to prevent toxicity, especially in patients with pre-existing liver conditions.

Additionally, voriconazole has been associated with visual disturbances, such as blurriness, altered color perception, and other visual phenomena, which can occur in a significant number of patients. Therefore, regular monitoring of visual function is important to address any adverse effects promptly.

The other aspects, while they may have their importance in specific contexts, are not as critical for voriconazole monitoring. Kidney function tests and a complete metabolic panel don't focus on the unique side effects and metabolic pathways of voriconazole to the same degree as liver function and visual function assessments. Blood glucose levels are not a direct concern with this antifungal agent, marking liver function tests and visual function as the key areas for monitoring during treatment.